Literature DB >> 21442720

Use of fully modified 2'-O-methyl antisense oligos for loss-of-function studies in vertebrate embryos.

Patricia N Schneider1, John T Olthoff, Abby J Matthews, Douglas W Houston.   

Abstract

Antisense oligonucleotides are commonly employed to study the roles of genes in development. Although morpholino phosphorodiamidate oligonucleotides (morpholinos) are widely used to block translation or splicing of target gene products' the usefulness of other modifications in mediating RNase-H independent inhibition of gene activity in embryos has not been investigated. In this study, we investigated the extent that fully modified 2'-O-methyl oligonucleotides (2'-OMe oligos) that can function as translation inhibiting reagents in vivo, using Xenopus and zebrafish embryos. We find that oligos against Xenopus β-catenin, wnt11, and bmp4 and against zebrafish chordin (chd), which can efficiently and specifically generate embryonic loss-of-function phenotypes comparable with morpholino injection and other methods. These results show that fully modified 2'-OMe oligos can function as RNase-H independent antisense reagents in vertebrate embryos and can thus serve as an alternative modification to morpholinos in some cases.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442720      PMCID: PMC3121920          DOI: 10.1002/dvg.20689

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  28 in total

Review 1.  Morpholino oligos: making sense of antisense?

Authors:  Janet Heasman
Journal:  Dev Biol       Date:  2002-03-15       Impact factor: 3.582

Review 2.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

Authors:  Peter Sazani; Ryszard Kole
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

3.  Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.

Authors:  C Boiziau; R Kurfurst; C Cazenave; V Roig; N T Thuong; J J Toulmé
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

4.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.

Authors:  P Dash; I Lotan; M Knapp; E R Kandel; P Goelet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 5.  2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation.

Authors:  M Manoharan
Journal:  Biochim Biophys Acta       Date:  1999-12-10

6.  Enzymatic amplification of translation inhibition of rabbit beta-globin mRNA mediated by anti-messenger oligodeoxynucleotides covalently linked to intercalating agents.

Authors:  C Cazenave; N Loreau; N T Thuong; J J Toulmé; C Hélène
Journal:  Nucleic Acids Res       Date:  1987-06-25       Impact factor: 16.971

7.  Effective targeted gene 'knockdown' in zebrafish.

Authors:  A Nasevicius; S C Ekker
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

8.  Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis.

Authors:  Petra Pandur; Matthias Läsche; Leonard M Eisenberg; Michael Kühl
Journal:  Nature       Date:  2002-08-08       Impact factor: 49.962

9.  Conserved requirement of Lim1 function for cell movements during gastrulation.

Authors:  Neil A Hukriede; Tania E Tsang; Raymond Habas; Poh-Lynn Khoo; Kirsten Steiner; Daniel L Weeks; Patrick P L Tam; Igor B Dawid
Journal:  Dev Cell       Date:  2003-01       Impact factor: 12.270

10.  Sequence-specific inhibition of small RNA function.

Authors:  György Hutvágner; Martin J Simard; Craig C Mello; Phillip D Zamore
Journal:  PLoS Biol       Date:  2004-02-24       Impact factor: 8.029

View more
  4 in total

1.  Conditional control of alternative splicing through light-triggered splice-switching oligonucleotides.

Authors:  James Hemphill; Qingyang Liu; Rajendra Uprety; Subhas Samanta; Michael Tsang; Rudolph L Juliano; Alexander Deiters
Journal:  J Am Chem Soc       Date:  2015-03-03       Impact factor: 15.419

2.  Caged oligonucleotides for bidirectional photomodulation of let-7 miRNA in zebrafish embryos.

Authors:  Julianne C Griepenburg; Brittani K Ruble; Ivan J Dmochowski
Journal:  Bioorg Med Chem       Date:  2013-05-09       Impact factor: 3.641

3.  A Novel Method for Gene-Specific Enhancement of Protein Translation by Targeting 5'UTRs of Selected Tumor Suppressors.

Authors:  Adam Master; Anna Wójcicka; Kamilla Giżewska; Piotr Popławski; Graham R Williams; Alicja Nauman
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

4.  Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.

Authors:  Dustin T King; Mark Barnes; Dana Thomsen; Chow H Lee
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.